Brian K. Kennedy, PhD, is the CEO and president of the Buck Institute for Research on Aging. His innovative work in the biology of aging began as a doctoral student at MIT, where he took part in groundbreaking studies under the guidance of Leonard Guarente, PhD. Currently, he studies the pathways that modulate longevity in life forms ranging from yeast to mice, particularly the rapamycin (TOR) pathway. One of his labs goals is to determine whether such pathways can be regulated to treat the diseases of aging. Previously, he was in the biochemistry department at the University of Washington in Seattle. Since 2006, he has served on the National Institutes of Health Cellular Mechanisms of Aging and Development study section and on the grant review committee for American Federation for Aging Research Grants. He has published more than 60 manuscripts in journals, including Cell, Nature, and Science, is an associate editor for the Journal of Gerontology, and consults for biotech and pharmaceutical companies.
More About Brian Kennedy
In this Tedx Talk, Brian Kennedy discusses how aging research can help individuals lead longer, healthier lives.
The current tools for extending healthy life better diets and regular exercise are effective. But there is room for improvement, especially in personalizing treatments.
Recent findings raise the question of whether it is possible to forestall aging as an approach to maintain vitality and delay the onset of multiple chronic diseases simultaneously.
Interventions that slow human aging will provide a powerful modality of preventive medicine: improving quality of life by keeping people healthy and productive while also providing economic benefits for society.
Kennedy leads the first independent institute in the USA that is dedicated to researching aging and its link to chronic diseases. Article begins on page 12.
In this radio interview, Kennedy discusses his research on the Sirtuin family of genes, genes that are associated with anti-aging in mammals.